Joinn Laboratories(China)Co.,Ltd.

Equities

603127

CNE100002W27

Biotechnology & Medical Research

End-of-day quote Shanghai S.E. 06:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
16.78 CNY -3.95% Intraday chart for Joinn Laboratories(China)Co.,Ltd. -8.56% -29.23%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Tranche Update on Joinn Laboratories(China)Co.,Ltd.'s Equity Buyback Plan announced on April 3, 2024. CI
Joinn Laboratories(China)Co.,Ltd. announces an Equity Buyback for CNY 100 million worth of its shares. CI
Joinn Laboratories' Profit Slumps 63% in 2023, Misses Estimates MT
Joinn Laboratories(China)Co.,Ltd. Proposes Final Dividend for the Year Ended December 31, 2023, Payable on 30 August 2024 CI
Joinn Laboratories(China)Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Joinn Laboratories(China)Co.,Ltd. authorizes a Buyback Plan. CI
MSCI to Remove 74 Companies From China Onshore Index Including China Southern Airlines, Weibo, Greentown China MT
Joinn Laboratories’ Actual Controller Receives Warning From Beijing Securities Regulator MT
Nomura Downgrades Joinn Laboratories (China) to Neutral From Buy, Adjusts Price Target to HK$12.60 From HK$20.93 MT
Nomura Downgrades Joinn Laboratories (China) to Neutral From Buy, Adjusts Price Target to 21.01 Yuan From 35 Yuan MT
Joinn Laboratories' 2023 Attributable Profit Seen to Decline; Shanghai Shares Fall 5% MT
Joinn Laboratories(China)Co.,Ltd. Provides Earnings Guidance for the Year Ended December 31, 2023 CI
Joinn Laboratories' Q3 Profit Falls 9% MT
Joinn Laboratories(China)Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Nomura Adjusts Joinn Laboratories' Price Target to 35 Yuan From 34.52 Yuan, Keeps at Buy MT
Nomura Adjusts Joinn Laboratories (China)'s Price Target to HK$20.93 From HK$20.64, Keeps at Buy MT
Nomura Adjusts Joinn Laboratories China's Price Target to HK$20.64 From HK$31.23, Keeps at Buy MT
Nomura Adjusts Joinn Laboratories China's Price Target to 34.52 Yuan From 49.19 Yuan, Keeps at Buy MT
Joinn Laboratories' H1 Attributable Profit Falls 76% MT
Joinn Laboratories(China)Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Joinn Laboratories (China) Expects Up to 80% Decline in First-Half Profit MT
Joinn Laboratories Expects First-Half Profit to Decline Up to 80% MT
Joinn Laboratories(China)Co.,Ltd. Provides Earnings Guidance for the Six Months Ended 30 June 2023 CI
Joinn Laboratories Co.,Ltd. Declares Final Dividend for the Year Ended December 31, 2022, Payable on 20 July 2023 CI
Joinn Laboratories Co.,Ltd. Proposes Final Dividend for the Year Ended December 31, 2022, Payable on 20 July 2023 CI
Chart Joinn Laboratories(China)Co.,Ltd.
More charts
Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The Company conducts its businesses both in the domestic market and overseas markets.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
16.78 CNY
Average target price
19.29 CNY
Spread / Average Target
+14.97%
Consensus
  1. Stock Market
  2. Equities
  3. 603127 Stock
  4. News Joinn Laboratories(China)Co.,Ltd.
  5. China’s Ban on Lab Monkey Imports Remains, Joinn Labs Insider Says; Shares Slide 5%